Toxicity and therapeutic efficacy of high-dose interleukin 2. In vivo infusion of antibody to NK-1.1 attenuates toxicity without compromising efficacy against murine leukemia.
J Exp Med (1989) 169 (1): 161–173.
Currently there are no citedby results. Try again later.
